Cargando…
Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
OBJECTIVES: The authors performed a systematic review and meta-analysis of randomized and nonrandomized trials on the efficacy of dexrazoxane in patients with breast cancer who were treated with anthracyclines with or without trastuzumab. BACKGROUND: Breast cancer treatment with anthracyclines and t...
Autores principales: | Macedo, Ariane V.S., Hajjar, Ludhmila A., Lyon, Alexander R., Nascimento, Bruno R., Putzu, Alessandro, Rossi, Lorenzo, Costa, Rafael B., Landoni, Giovanni, Nogueira-Rodrigues, Angélica, Ribeiro, Antonio L.P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352186/ https://www.ncbi.nlm.nih.gov/pubmed/34396164 http://dx.doi.org/10.1016/j.jaccao.2019.08.003 |
Ejemplares similares
-
Dexrazoxane for Preventing Anthracycline Cardiotoxicity in Children with Solid Tumors
por: Choi, Hyoung Soo, et al.
Publicado: (2010) -
Anthracycline extravasation injuries: management with dexrazoxane
por: Jordan, Karin, et al.
Publicado: (2009) -
What is the Role of Two-Dimensional Speckle Tracking Echocardiography
in the Diagnosis and Management of Anthracycline-Induced
Cardiotoxicity?
por: Costa, Isabela Bispo Santos da Silva, et al.
Publicado: (2018) -
Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case series
por: Ganatra, Sarju, et al.
Publicado: (2019) -
Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death
por: Popelová, O, et al.
Publicado: (2009)